944
Participants
Start Date
August 14, 2014
Primary Completion Date
May 15, 2019
Study Completion Date
May 15, 2019
transplant
All subjects enrolled in this study are candidates for/recipients of solid organ transplants as a therapeutic for end stage diseases (e.g., heart, liver, heart with liver, kidney, small intestine, or liver with small intestine transplants).
Immunosuppressive Drugs
Immunosuppressive drugs prescribed as standard of care to prevent rejection of the allograft.
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Medstar Georgetown Transplant Institute, Washington D.C.
University of Miami Health System, Miami
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Texas Southwestern, Dallas
University of California, Los Angeles, Los Angeles
Lucile Packard Children's Hospital Stanford, Stanford
Clinical Trials in Organ Transplantation in Children
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH